Alkermes PLC
Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies (EDT), the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of ALKS would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1991) — listing | $197,541 3.7× | $286,631 3.7× |
| Year 6 (1996) | $108,652 2.4× | $158,022 2.4× |
| Year 11 (2001) | $79,719 2.1× | $115,907 2.1× |
| Year 16 (2006) | $56,987 1.9× | $82,782 1.9× |
| Year 21 (2011) | $33,413 1.4× | $48,564 1.4× |
| Year 26 (2016) | $21,840 1.4× | $31,723 1.4× |
| Year 31 (2021) | $12,023 1.5× | $17,510 1.5× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Dublin, Ireland
Popular scenarios with ALKS
For illustration only — not investment advice. Past performance is not indicative of future results.